Welcome to LookChem.com Sign In|Join Free

CAS

  • or
N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE is a complex chemical compound derived from N-methyl alpha carbobenzyloxyglycine, featuring a methoxy group and a methylamide moiety. It is a promising candidate in pharmaceutical research and development, particularly in the field of medicinal chemistry, due to its potential biological activities and role as a pharmacological agent.

121505-94-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 121505-94-0 Structure
  • Basic information

    1. Product Name: N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE
    2. Synonyms: N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE;Carbamic acid, N-[2-(methoxymethylamino)-2-oxoethyl]-, phenylmethyl ester;Benzyl (2-(methoxy(methyl)amino)-2-oxoethyl)carbamate;benzyl N-{[methoxy(methyl)carbamoyl]methyl}carbamate
    3. CAS NO:121505-94-0
    4. Molecular Formula: C12H16N2O4
    5. Molecular Weight: 252.27
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 121505-94-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE(CAS DataBase Reference)
    10. NIST Chemistry Reference: N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE(121505-94-0)
    11. EPA Substance Registry System: N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE(121505-94-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 121505-94-0(Hazardous Substances Data)

121505-94-0 Usage

Uses

Used in Pharmaceutical Research and Development:
N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE is used as a building block for the synthesis of novel drug candidates, leveraging its potential biological activities and pharmacological properties.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE is utilized for its potential role as a pharmacological agent, with ongoing investigations into its precise mechanisms of action and potential applications.

Check Digit Verification of cas no

The CAS Registry Mumber 121505-94-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,5,0 and 5 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 121505-94:
(8*1)+(7*2)+(6*1)+(5*5)+(4*0)+(3*5)+(2*9)+(1*4)=90
90 % 10 = 0
So 121505-94-0 is a valid CAS Registry Number.

121505-94-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Benzyl {2-[methoxy(methyl)amino]-2-oxoethyl}carbamate

1.2 Other means of identification

Product number -
Other names Fmoc-Dpr(Boc)-OH

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121505-94-0 SDS

121505-94-0Relevant articles and documents

Efficient preparation of stereopure amphiphilic 1,2-amino alcohols by using preparative enantioselective HPLC

Kanai, Hayato,Yamada, Kuniyo,Kodama, Koichi,Ishida, Yasuhiro

, p. 295 - 305 (2021/11/22)

Chiral amphiphiles are useful for controlling the structures and properties of supramolecular assemblies, but their stereocontrolled synthesis is generally difficult, because their long alkyl chains tend to bring unfavorable effects on the solubility, rea

SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS

-

Page/Page column 108-109, (2021/05/21)

The application relates to substituted hydantoinamides of formula (I) as ADAMTS7 antagonists, to processes for their preparation, their use alone or in combination for the treatment or prophylaxis of diseases, in particular of cardiovascular diseases, including atherosclerosis, coronary artery disease (CAD), peripheral vascular disease (PAD), arterial occlusive disease or restenosis after angioplasty. R1 is hydrogen, alkyl, cycloalkyl, heterocycloalkyl, 5- to 6-membered heteroaryl or phenyl; R2 is hydrogen or alkyl; A is 5-membered heteroaryl; Z is 6- to 10-membered aryl or 5- to 10-membered heteroaryl; all groups being optionally substituted.

α-Amino Aldehydes as Readily Available Chiral Aldehydes for Rh-Catalyzed Alkyne Hydroacylation

Hooper, Joel F.,Seo, Sangwon,Truscott, Fiona R.,Neuhaus, James D.,Willis, Michael C.

supporting information, p. 1630 - 1634 (2016/02/20)

Readily available α-amino aldehydes, incorporating a methylthiomethyl (MTM) protecting group on nitrogen, are shown to be efficient substrates in Rh-catalyzed alkyne hydroacylation reactions. The reactions are performed under mild conditions, employing a small-bite-angle bis-phosphine ligand, allowing for good functional group tolerance with high stereospecificity. Amino aldehydes derived from glycine, alanine, valine, leucine, phenylalanine, isoleucine, serine, tryptophan, methionine, and cysteine were successfully employed, as was an enantiomerically enriched α-OMTM-aldehyde derived from phenyllactic acid. The synthetic utility of the α-amino enone products is demonstrated in a short enantioselective synthesis of the natural product sphingosine.

The discovery of potent, selective, and reversible inhibitors of the house dust mite peptidase allergen der p 1: An innovative approach to the treatment of allergic asthma

Newton, Gary K.,Perrior, Trevor R.,Jenkins, Kerry,Major, Meriel R.,Key, Rebekah E.,Stewart, Mark R.,Firth-Clark, Stuart,Lloyd, Steven M.,Zhang, Jihui,Francis-Newton, Nicola J.,Richardson, Jonathan P.,Chen, Jie,Lai, Pei,Garrod, David R.,Robinson, Clive

supporting information, p. 9447 - 9462 (2015/01/16)

Blocking the bioactivity of allergens is conceptually attractive as a small-molecule therapy for allergic diseases but has not been attempted previously. Group 1 allergens of house dust mites (HDM) are meaningful targets in this quest because they are globally prevalent and clinically important triggers of allergic asthma. Group 1 HDM allergens are cysteine peptidases whose proteolytic activity triggers essential steps in the allergy cascade. Using the HDM allergen Der p 1 as an archetype for structure-based drug discovery, we have identified a series of novel, reversible inhibitors. Potency and selectivity were manipulated by optimizing drug interactions with enzyme binding pockets, while variation of terminal groups conferred the physicochemical and pharmacokinetic attributes required for inhaled delivery. Studies in animals challenged with the gamut of HDM allergens showed an attenuation of allergic responses by targeting just a single component, namely, Der p 1. Our findings suggest that these inhibitors may be used as novel therapies for allergic asthma.

Autotandem catalysis: Synthesis of pyrroles by gold-catalyzed cascade reaction

Ueda, Hirofumi,Yamaguchi, Minami,Kameya, Hiroshi,Sugimoto, Kenji,Tokuyama, Hidetoshi

supporting information, p. 4948 - 4951 (2015/04/27)

A novel synthesis of substituted pyrroles by a gold(I)-catalyzed cascade reaction has been developed. The reaction proceeded with an autotandem catalysis consisting of an initial addition of gold-acetylide to an acetal moiety and was followed by gold-catalyzed 5-endo-dig cyclization and aromatization. Gold catalysts play a dual role in activating nucleophilicity or electrophilicity of terminal acetylenes by forming gold-acetylides or by π-coordination. The formal (3 + 2) annulation of two components provided a variety of substituted pyrroles in a modular fashion.

Metallo-foldamers with backbone-coordinative oxime peptides: Control of secondary structures

Tashiro, Shohei,Matsuoka, Koji,Minoda, Ai,Shionoya, Mitsuhiko

supporting information, p. 13123 - 13127 (2013/02/26)

A new series of square-planar PdII-mediated foldamers with mononuclear and dinuclear helix or (double) hairpin structures were constructed by novel backbonecoordinative oxime peptides. Some of these metallo-foldamers allow significant structura

METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR

-

Page/Page column 41, (2012/06/16)

The present invention provides compounds of Formula (I) that are useful for binding and/or modulating the biological activity of the melanocortin-1 receptor (MC1R). Compounds of this invention can be used to treat diseases and/or conditions in which modulation of MC1R is beneficial. Such diseases and/or conditions include, but are not limited to, hyperpigmentation (including melasma), hypopigmentation (including vitiligo), melanoma, basal cell carcinoma, squamous cell carcinoma, erythropoietic protoporphyria, polymorphous light eruption, solar urticaria, photosensitivity, sunburn, inflammatory diseases, aberrant fibroblast activity and pain.

On the reactivity of imidazole carbamates and ureas and their use as esterification and amidation reagents

Heller, Stephen T.,Sarpong, Richmond

experimental part, p. 8851 - 8859 (2011/12/02)

The optimization, substrate scope, and mechanism of esterification and amidation of carboxylic acids mediated by imidazole-based reagents are discussed. The innate reactivity of carbonylimidazole reagents with a range of nucleophiles is also explored. New reagents developed for the synthesis of α,β-unsaturated esters are described, as are reagents for the preparation of tertiary amides directly from carboxylic acids.

METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR

-

Page/Page column 72-73, (2010/09/17)

The present invention provides compounds of Formula (I) that are useful for binding and/or modulating the biological activity of the melanocortin-1 receptor (MC1R). Compounds of this invention can be used to treat diseases and/or conditions in which modulation of MC1R is beneficial. Such diseases and/or conditions include, but are not limited to, hyperpigmentation (including melasma), hypopigmentation (including vitiligo), melanoma, basal cell carcinoma, squamous cell carcinoma, erythropoietic protoporphyria, polymorphous light eruption, solar urticaria, photosensitivity, sunburn, inflammatory diseases, aberrant fibroblast activity and pain.

METHODS OF MODULATING THE ACTIVITY OF THE MC3 AND/OR MC4 RECEPTORS AND TREATMENT OF CONDITIONS RELATED TO THESE RECEPTORS

-

Page/Page column 88, (2010/09/17)

The present invention provides compounds of Formula (I) that are useful for modulating the biological activity of the melanocortin-3 receptor (MC3R) and / or the melanocortin-4 receptor (MC4R). Compounds of this invention can be used to treat diseases and/or conditions in which modulation of MC3R and / or MC4R is beneficial. Such diseases and/or conditions include, but are not limited to, obesity, eating disorders (such as cachexia, anorexia, weight gain, weight loss), metabolic syndrome, diabetes, sexual dysfunction (such as erectile dysfunction and female sexual dysfunction), anxiety, depression, inflammation, addiction and alcohol intake.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121505-94-0